(Q84804219)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21858537%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

Evaluation of multiple serum markers in advanced melanoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21858537%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Angel Díaz-Lagares

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21858537%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Estíbaliz Alegre

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21858537%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Ainhoa Arroyo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21858537%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

María González-Cao

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21858537%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Maria E Zudaire

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21858537%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Santiago Viteri

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21858537%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Salvador Martín-Algarra

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21858537%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Alvaro González

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21858537%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

20 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21858537%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21858537%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21858537%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21858537%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

1155-1161

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21858537%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s13277-011-0218-x

11 February 2020

exact match

0 references

cites work

Positron emission tomography plus serum TA90 immune complex assay for detection of occult metastatic melanoma

1 reference

12 December 2020

S100 beta is a more reliable tumor marker in peripheral blood for patients with newly occurred melanoma metastases compared with MIA, albumin and lactate-dehydrogenase

1 reference

12 December 2020

S100-Beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanoma

1 reference

12 December 2020

IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. International Federation of Clinical Chemistry and Laboratory Medicine. Part 7. Certification of four reference materials for the

1 reference

12 December 2020

Increased level of YKL-40 in sera from patients with early rheumatoid arthritis: a new marker for disease activity

1 reference

12 December 2020

Diagnostic value and prognostic significance of protein S-100beta, melanoma-inhibitory activity, and tyrosinase/MART-1 reverse transcription-polymerase chain reaction in the follow-up of high-risk melanoma patients

1 reference

12 December 2020

Melanoma inhibiting activity protein (MIA), beta-2 microglobulin and lactate dehydrogenase (LDH) in metastatic melanoma

1 reference

12 December 2020

Plasma YKL-40 and total and disease-specific mortality in the general population

1 reference

12 December 2020

S100B protein detection in serum is a significant prognostic factor in metastatic melanoma

1 reference

12 December 2020

Structure and promoter analysis of the gene encoding the human melanoma-inhibiting protein MIA

1 reference

12 December 2020

Predicting outcome in melanoma: where are we now?

1 reference

12 December 2020

Plasma markers for identifying patients with metastatic melanoma

1 reference

12 December 2020

S100 proteins as cancer biomarkers with focus on S100B in malignant melanoma

1 reference

12 December 2020

Identification of a 38-kDa heparin-binding glycoprotein (gp38k) in differentiating vascular smooth muscle cells as a member of a group of proteins associated with tissue remodeling

1 reference

12 December 2020

S-100B concentrations predict disease-free survival in stage III melanoma patients

1 reference

12 December 2020

Melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

1 reference

12 December 2020

Short German guidelines: malignant melanoma

1 reference

12 December 2020

S-100beta and MIA in advanced melanoma in relation to prognostic factors

1 reference

12 December 2020

Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer

1 reference

12 December 2020

Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma

1 reference

12 December 2020

Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma

1 reference

12 December 2020

Long-term survival analysis in metastatic melanoma: serum S100B is an independent prognostic marker and superior to LDH.

1 reference

12 December 2020

Evaluation of new putative tumor markers for melanoma

1 reference

12 December 2020

Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline

1 reference

12 December 2020

Immunohistochemical characteristics of melanoma

1 reference

12 December 2020

A Comparison of 3 tumor markers (MIA, TA90IC, S100B) in stage III melanoma patients

1 reference

12 December 2020

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma

1 reference

12 December 2020

Differential screening identifies genetic markers of monocyte to macrophage maturation

1 reference

12 December 2020

Updated Swiss Guidelines for the Treatment and Follow-Up of Cutaneous Melanoma

1 reference

12 December 2020

Revised U.K. guidelines for the management of cutaneous melanoma 2010

1 reference

12 December 2020

Clinical value of combined determination of plasma L-DOPA/tyrosine ratio, S100B, MIA and LDH in melanoma

1 reference

12 December 2020

Serum S-100 protein: a potentially useful prognostic marker in cutaneous melanoma

1 reference

12 December 2020

Serological markers for melanoma

1 reference

12 December 2020

Diagnostic value of melanoma inhibitory activity serum marker in the follow-up of patients with stage I or II cutaneous melanoma.

1 reference

12 December 2020

Serum YKL-40, a new prognostic biomarker in cancer patients?

1 reference

12 December 2020

Biomarkers in melanoma

1 reference

12 December 2020

Prognostic significance of serum S100B protein in high-risk surgically resected melanoma patients participating in Intergroup Trial ECOG 1694.

1 reference

12 December 2020

Is YKL-40 a new therapeutic target in cancer?

1 reference

12 December 2020